PCM
Prelude Capital Management Portfolio holdings
AUM
$1.02B
1-Year Return
30.93%
This Quarter Return
+7.63%
1 Year Return
+30.93%
3 Year Return
+112.01%
5 Year Return
+170.21%
10 Year Return
+650.33%
AUM
$1.46B
AUM Growth
+$309M
(+27%)
Cap. Flow
+$248M
Cap. Flow
% of AUM
17%
Top 10 Holdings %
Top 10 Hldgs %
11.02%
Holding
1,478
New
464
Increased
391
Reduced
281
Closed
264
Top Buys
| 1 |
NVIDIA
NVDA
|
+$12.5M |
| 2 |
Baidu
BIDU
|
+$11.9M |
| 3 |
Bumble
BMBL
|
+$10.1M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$6.32M |
| 5 |
Mercury Systems
MRCY
|
+$6.09M |
Top Sells
| 1 |
New Oriental
EDU
|
+$14.3M |
| 2 |
KE Holdings
BEKE
|
+$12.5M |
| 3 |
Alibaba
BABA
|
+$11.2M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$11.1M |
| 5 |
Li Auto
LI
|
+$10.8M |
Sector Composition
| 1 | Technology | 18.54% |
| 2 | Consumer Discretionary | 13.5% |
| 3 | Healthcare | 12.83% |
| 4 | Industrials | 12.57% |
| 5 | Energy | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Quad
QUAD
$327M
| $87.5K | ﹤0.01% |
16,484
+4,200
| +34% | +$22.3K |
|
1102
KLX Energy Services
KLXE
$34.1M
| $86.5K | ﹤0.01% |
11,171
-9,693
| -46% | -$75K |
|
|
WHWK
1103
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.4M
| $85.6K | ﹤0.01% |
36,597
+10,200
| +39% | +$23.9K |
|
1104
P10
PX
$1.34B
| $85.3K | ﹤0.01% |
+10,131
| New | +$85.3K |
|
1105
Expensify
EXFY
$174M
| $85.2K | ﹤0.01% |
46,300
-5,000
| -10% | -$9.2K |
|
1106
Absci
ABSI
$356M
| $82.9K | ﹤0.01% |
+14,600
| New | +$82.9K |
|
|
BORR
1107
Borr Drilling
BORR
$884M
| $82.5K | ﹤0.01% |
+12,044
| New | +$82.5K |
|
1108
BRC Inc
BRCC
$174M
| $81.4K | ﹤0.01% |
+19,023
| New | +$81.4K |
|
1109
WM Technology
MAPS
$131M
| $80.9K | ﹤0.01% |
+60,845
| New | +$80.9K |
|
|
ADAG
1110
Adagene
ADAG
$113M
| $80.1K | ﹤0.01% |
+28,620
| New | +$80.1K |
|
1111
Lantronix
LTRX
$184M
| $79.6K | ﹤0.01% |
+22,366
| New | +$79.6K |
|
1112
Ovid Therapeutics
OVID
$88.9M
| $77.9K | ﹤0.01% |
+25,555
| New | +$77.9K |
|
|
CMLS
1113
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $76.9K | ﹤0.01% |
21,413
| – | – |
|
1114
Esperion Therapeutics
ESPR
$524M
| $74.9K | ﹤0.01% |
27,963
-1,828
| -6% | -$4.9K |
|
1115
SelectQuote
SLQT
$339M
| $74.1K | ﹤0.01% |
+37,025
| New | +$74.1K |
|
|
BCOV
1116
DELISTED
Brightcove, Inc.
BCOV
| $70.2K | ﹤0.01% |
36,168
+3,368
| +10% | +$6.53K |
|
1117
Harvard Bioscience
HBIO
$20M
| $70.1K | ﹤0.01% |
16,528
| – | – |
|
1118
OPAL Fuels
OPAL
$63.5M
| $70.1K | ﹤0.01% |
13,960
+3,609
| +35% | +$18.1K |
|
|
VIGL
1119
DELISTED
Vigil Neuroscience
VIGL
| $69.5K | ﹤0.01% |
+20,377
| New | +$69.5K |
|
|
SRTA
1120
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$326M
| $68.7K | ﹤0.01% |
+24,100
| New | +$68.7K |
|
1121
Pacific Biosciences
PACB
$366M
| $66.9K | ﹤0.01% |
17,850
-2,309
| -11% | -$8.66K |
|
1122
Amneal Pharmaceuticals
AMRX
$3.08B
| $65.7K | ﹤0.01% |
+10,841
| New | +$65.7K |
|
1123
Prelude Therapeutics
PRLD
$67.4M
| $65.6K | ﹤0.01% |
13,846
-500
| -3% | -$2.37K |
|
1124
Aurora
AUR
$10B
| $65.4K | ﹤0.01% |
+23,180
| New | +$65.4K |
|
1125
Adicet Bio
ACET
$66.9M
| $65.4K | ﹤0.01% |
+27,810
| New | +$65.4K |
|